tiprankstipranks
Sumitomo Seika Chemicals Co., Ltd. (JP:4008)
:4008
Japanese Market

Sumitomo Seika Chemicals Co., Ltd. (4008) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4008

Sumitomo Seika Chemicals Co., Ltd.

(4008)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
¥6,667.00
▲(23.46% Upside)
Action:UpgradedDate:02/21/26
The score is driven primarily by solid financial performance (consistent revenue growth and stable margins) and strong technical trend strength. These positives are offset by volatile free cash flow and overbought technical readings, while valuation is only moderately supportive due to the P/E level despite a reasonable dividend yield.
Positive Factors
Operating efficiency
Strong EBIT/EBITDA margins indicate durable operating efficiency across product lines. High operating margins support internal cash generation, help absorb input-cost swings, and fund R&D or capacity upkeep, sustaining competitiveness and profitability over multiple market cycles.
Negative Factors
Free cash flow volatility
Significant FCF volatility and a recent downturn weaken the firm's ability to consistently fund capex, pay down debt, or return cash to shareholders. Persistent swings in free cash flow increase refinancing and planning risk, complicating long-term investment and payout strategies.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating efficiency
Strong EBIT/EBITDA margins indicate durable operating efficiency across product lines. High operating margins support internal cash generation, help absorb input-cost swings, and fund R&D or capacity upkeep, sustaining competitiveness and profitability over multiple market cycles.
Read all positive factors

Sumitomo Seika Chemicals Co., Ltd. (4008) vs. iShares MSCI Japan ETF (EWJ)

Sumitomo Seika Chemicals Co., Ltd. Business Overview & Revenue Model

Company Description
Sumitomo Seika Chemicals Company, Limited manufactures and sells absorbent polymers, functional chemicals, and gases in Japan and internationally. The company offers sodium polyacrylate-based super absorbent polymer for use in hygiene products, in...
How the Company Makes Money
The company makes money primarily by manufacturing and selling chemical products to corporate customers (B2B) across domestic and export markets. Its core revenue stream is product sales from functional materials, with superabsorbent polymers (SAP...

Sumitomo Seika Chemicals Co., Ltd. Financial Statement Overview

Summary
Solid overall fundamentals supported by consistent revenue growth and stable gross margins. Operating efficiency is strong (EBIT/EBITDA margins), but net margin variability and volatile free cash flow—especially the latest downturn—temper the score.
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue146.24B147.57B142.99B143.04B115.58B103.25B
Gross Profit30.38B30.39B27.72B29.93B26.00B24.99B
EBITDA15.62B16.45B15.28B15.55B12.97B15.38B
Net Income4.49B5.96B6.17B8.59B5.90B7.12B
Balance Sheet
Total Assets141.32B141.53B136.31B126.65B121.27B107.83B
Cash, Cash Equivalents and Short-Term Investments18.93B16.86B21.66B23.55B29.25B25.66B
Total Debt22.29B18.86B11.57B12.62B14.55B14.09B
Total Liabilities47.05B47.22B41.25B39.99B39.37B32.34B
Stockholders Equity94.26B94.31B95.05B86.66B78.73B72.80B
Cash Flow
Free Cash Flow0.00-5.98B3.80B1.80B5.39B13.18B
Operating Cash Flow0.0013.68B12.01B6.70B9.02B16.25B
Investing Cash Flow0.00-20.91B-10.37B-9.61B-4.32B-2.23B
Financing Cash Flow0.003.19B-5.77B-4.63B-2.99B-3.26B

Sumitomo Seika Chemicals Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price5400.00
Price Trends
50DMA
6214.00
Negative
100DMA
5722.15
Positive
200DMA
5105.25
Positive
Market Momentum
MACD
-11.94
Positive
RSI
37.56
Neutral
STOCH
3.83
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4008, the sentiment is Neutral. The current price of 5400 is below the 20-day moving average (MA) of 6758.00, below the 50-day MA of 6214.00, and above the 200-day MA of 5105.25, indicating a neutral trend. The MACD of -11.94 indicates Positive momentum. The RSI at 37.56 is Neutral, neither overbought nor oversold. The STOCH value of 3.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4008.

Sumitomo Seika Chemicals Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥298.55B9.055.47%3.41%2.60%9.50%
70
Outperform
¥83.56B10.343.74%-0.68%-9.93%
67
Neutral
¥746.10B77.75-2.50%3.49%-6.83%-123.67%
65
Neutral
¥267.81B11.039.45%2.65%-0.04%3.15%
65
Neutral
¥236.71B6.131.47%4.29%-7.45%-71.68%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
¥707.87B12.792.01%3.82%-4.63%-65.11%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
6,230.00
1,303.69
26.46%
JP:4118
Kaneka
4,721.00
846.65
21.85%
JP:4182
Mitsubishi Gas Chemical Company
3,846.00
1,477.09
62.35%
JP:4183
Mitsui Chemicals
1,884.00
140.20
8.04%
JP:4043
Tokuyama
3,722.00
897.40
31.77%
JP:4208
UBE Industries
2,475.00
268.96
12.19%

Sumitomo Seika Chemicals Co., Ltd. Corporate Events

Sumitomo Seika Advances Share Buyback, Reaching Over Two-Thirds of Authorized Amount
Mar 3, 2026
Sumitomo Seika Chemicals has reported the latest progress of its share buyback program authorized by its board in November 2025. Between February 1 and February 28, 2026, the company repurchased 35,100 of its own common shares on the Tokyo Stock E...
Sumitomo Seika Announces 5-for-1 Share Split and Revises Shareholder Benefits
Feb 9, 2026
Sumitomo Seika Chemicals will implement a five-for-one share split of its common stock, effective April 1, 2026, aiming to lower the investment unit price, enhance stock liquidity, and broaden its shareholder base. The move will increase issued sh...
Sumitomo Seika Lifts Full-Year Profit, Dividend Outlook Despite Earnings Dip
Feb 9, 2026
Sumitomo Seika Chemicals reported nine-month consolidated net sales of ¥111.7 billion, down slightly year on year, while operating profit rose 18.7% to ¥10.3 billion and ordinary profit increased 9.3%. Profit attributable to owners of th...
Sumitomo Seika Hikes Earnings Outlook and Dividend on Weaker Yen and Polymer Sales
Feb 9, 2026
Sumitomo Seika Chemicals has raised its full-year consolidated forecast for the fiscal year ending March 31, 2026, citing a weaker yen, lower raw material and fuel costs, and higher sales volumes of water-soluble polymers. The company now expects ...
Sumitomo Seika Books Large Extraordinary Loss Over Product Mischarging Case
Feb 9, 2026
Sumitomo Seika Chemicals will book an extraordinary loss in the third quarter of the fiscal year ending March 31, 2026, stemming from a previously disclosed case of product price mischarging at one of its subsidiaries. After continued negotiations...
Sumitomo Seika Reports Progress on Ongoing Share Buyback Program
Feb 3, 2026
Sumitomo Seika Chemicals has disclosed the latest status of its ongoing share buyback program authorized by its board in November 2025. Between January 1 and January 31, 2026, the company repurchased 43,300 shares of its common stock for a total o...
Sumitomo Seika Director Resigns From Audit and Supervisory Committee for Health Reasons
Jan 30, 2026
Sumitomo Seika Chemicals Co., Ltd. has announced that Independent External Director and Audit and Supervisory Committee member Fujio Yoshiike has resigned from the Board as of January 30, 2026, due to health reasons. The company stated that, despi...
Sumitomo Seika Reports Progress on Share Buyback Program
Jan 6, 2026
Sumitomo Seika Chemicals has reported on the progress of its board-approved share buyback program, authorized in November 2025 under the Companies Act and its Articles of Incorporation. Between December 1 and December 31, 2025, the company repurch...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 21, 2026